Visit our social media pages

#4 – Is biohacking big business?

15. March 2017by ECSA
ECSA News - Is biohacking big business?
eu_logo_ditos

#4 – Is biohacking big business?

Originally published by Pieter van Boheemen here

In this edition, Pieter talks with two people that started their own biotech company: Frederico Muffatto of Digibio and Steven O’Connell of RebelBio, a startup accelerator which focuses on entrepreneurs building technologies in or around the field of Biotech.

 

ECSA